US Patent 9879087 Glycan-interacting compounds and methods of use
Patent 9879087 was granted and assigned to Siamab Therapeutics, Inc. on January, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9879087 Glycan-interacting compounds and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.